Reversing latent HIV with mRNA and lipid nanoparticles: A promising new strategy
By Bridget Fisher and Dr Michael Moso Latent HIV that remains ‘silent’ in CD4 T cells is a major barrier
latency
Gene therapy advance in mice
A special session at the recent Australasian HIV/AIDS conference featured new research from the Kirby Institute. Dr Scott Ledger presented
HIV cure snapshot
The Australasian HIV&AIDS Conference (commonly known as ASHM after the organiser, the Australasian Society for HIV Medicine) was held online
Block and lock: a pathway to remission
‘Block and lock’ is an emerging option in the pursuit of an HIV cure. Kirby Institute researchers have developed an
The promise and challenge of stem cell transplants in HIV cure
The only confirmed case of HIV cure, and two cases of long-term remission without treatment, are the result of stem
Key lessons from Keystone
Keystone symposia bring together focused groups of scientists to discuss unpublished research. They provide insights into the current thinking around
HIV reservoir changes dramatically during prolonged ART
HIV integration into the host genome, forming the HIV reservoir, represents the major barrier to HIV eradication. It is not
New clue about HIV latency maintenance
Yale researchers have highlighted the role of APOBEC3A (A3A) in sustaining HIV latency. A3A is typically found in immune cells
What should a functional cure for HIV aim to do?
What might a functional cure for HIV look like? In a recent study, researchers assumed that HIV reactivation from latency
Combination strategy delays virus rebound in monkeys
Harvard researchers have published exciting results on a combination approach to tackling latent HIV. In a monkey model of HIV
Stigma, seroconversion and the search for an HIV cure
Reducing the persistent stigma and discrimination related to HIV infection drives clinician scientist Jintanat Ananworanich. Her research interests range from
VIVA trial: Vitamin D in HIV latency
The current standard treatment for people living with HIV is a combination of drugs known as antiretroviral therapy (or ART).